![Valentin Fulga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Valentin Fulga
Chief Executive Officer at Theravitae Co. Ltd.
Profile
Valentin Fulga is the founder.
He founded Theravitae Co. Ltd.
in 2003 and currently holds the title of Chief Executive Officer.
Dr. Fulga also held former positions at TheraVitae, Inc. as Chairman, President & Chief Executive Officer, at Hemostemix, Inc. as Director, and at W World Corp.
as Principal.
Dr. Fulga obtained an undergraduate degree from Ben-Gurion University of the Negev.
Valentin Fulga active positions
Companies | Position | Start |
---|---|---|
Theravitae Co. Ltd.
![]() Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Theravitae Co. Ltd. offers stem cell therapies for cardiac patients. Its product includes VesCell that is used in curing coronary heart disease, congestive heart failure and cardiomyopathy. The company was founded by Robert Clark and Valentin Fulga in 2003 and is headquartered in Bangkok, Thailand. | Chief Executive Officer | 2002-12-31 |
Former positions of Valentin Fulga
Companies | Position | End |
---|---|---|
W WORL | Corporate Officer/Principal | - |
HEMOSTEMIX INC. | Director/Board Member | - |
TheraVitae, Inc.
![]() TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Chief Executive Officer | - |
Training of Valentin Fulga
Ben-Gurion University of the Negev | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
W WORL | Health Technology |
HEMOSTEMIX INC. | Health Technology |
Private companies | 2 |
---|---|
TheraVitae, Inc.
![]() TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Health Technology |
Theravitae Co. Ltd.
![]() Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Theravitae Co. Ltd. offers stem cell therapies for cardiac patients. Its product includes VesCell that is used in curing coronary heart disease, congestive heart failure and cardiomyopathy. The company was founded by Robert Clark and Valentin Fulga in 2003 and is headquartered in Bangkok, Thailand. | Health Technology |
- Stock Market
- Insiders
- Valentin Fulga